$PAVM

$2.14 -$0.12 (5.31%) Close

$PAVM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 8.0M shares outstanding

Who owns PAVM?

By type of holder

Institutions 11.7% Insiders 23.5% Everyone else 64.8%

Concentration Top 10 holders own 33.3%

Tasso Partners, LLC 11.4% · Two Seas Capital LP 5.8%

Institutional ownership

11.7%

+5.3 pts vs last qtr

Institutional holders

-1 vs last qtr

Net shares bought

+423.8K

by institutions in Q2 2026

New / sold out

4 / 5

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

First Manhattan Co. LLC. +309.1K
Vanguard Capital Management LLC +55.7K

Biggest sellers in Q2 2026

Tower Research Capital LLC (TRC) SOLD OUT −622
CWM, LLC SOLD OUT −157

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for PAVmed Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2025

−88.7%

−51.67% a year

Each share's claim on the business

+785.7%

grew without buying or selling a share

Spent on buybacks vs paid in stock

— vs $38.8M

over 4 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years51% Under 1 year49%

Quarterly turnover

41.5%

of institutional shares changed hands

Top 10 managers, median time held

2.5 years

Super Investors

Investment managers reporting PAVM on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
TS Two Seas Capital LP	461.5K	5.77%	Unchanged	Q1 '26	0.1%
Shares held by quarter Peak holding461.5K (Q1'26) Change over 8 quarters+461.5K Share of the company5.770% Two Seas Capital LP's full portfolio →
FM First Manhattan Co. LLC.	332.9K	4.16%	+309.1K (+1298.5%)	2023	0.0%
Shares held by quarter Peak holding714.1K (Q1'25) Change over 8 quarters−267.1K Share of the company4.160% First Manhattan Co. LLC.'s full portfolio →

Two Seas Capital LP

461.5K

% of company

5.77%

Change vs last qtr

Unchanged

Held since

Q1 '26

First Manhattan Co. LLC.

332.9K

% of company

4.16%

Change vs last qtr

+309.1K (+1298.5%)

Held since

2023

22 more super investors behind a free account

See every manager holding PAVmed Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting PAVM on Form N-PORT; together they hold 1.4% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$344K	57.9K	0.72%	0.00%	June 30, 2026
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$166K	31.8K	0.40%	0.00%	August 31, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$344K

% of company

0.72%

% of the fund

0.00%

As of

June 30, 2026

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$166K

% of company

0.40%

% of the fund

0.00%

As of

August 31, 2026

6 more funds behind a free account

See every fund holding PAVmed Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
TP Tasso Partners, LLC Insider	913.0K	11.42%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company11.420% Tasso Partners, LLC's insider activity →
AL Aklog Lishan 5%+ holder 13D · 5.1%	369.1K	4.62%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company4.620% Disclosed stake13D · 5.1% View the 13D/G filing →

Tasso Partners, LLC

Insider

913.0K

% of company

11.42%

Change vs last qtr

—

Held since

—

Aklog Lishan

5%+ holder13D · 5.1%

369.1K

% of company

4.62%

Change vs last qtr

—

Held since

—

9 more holders behind a free account

See every insider and 5%+ holder of PAVmed Inc.

Comments